Jefferies Group LLC Xenon Pharmaceuticals Inc. Transaction History

Jefferies Group LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Sep 21, 2023	BUY	$25.44 - $35.16 $696,394 - $962,469	27,374 Added 6029.52%	27,828 $846,000
Q2 2022 Aug 15, 2022	BUY	$25.44 - $35.16 $710,920 - $982,546	27,945 New	27,945 $847,000
Q1 2022 May 16, 2022	SELL	$25.09 - $33.13 $11,390 - $15,041	-454 Closed	0 $0
Q4 2021 Sep 21, 2023	BUY	$15.6 - $35.4 $7,082 - $16,071	454 New	454 $14,000
Q4 2021 Feb 14, 2022	BUY	$15.6 - $35.4 $7,082 - $16,071	454 New	454 $14,000
Q4 2018 Feb 14, 2019	SELL	$5.61 - $12.62 $1.83 Million - $4.11 Million	-325,630 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$9.0 - $14.9 $2.93 Million - $4.85 Million	325,630 New	325,630 $4.3 Million

212

70.2M

88.3K

28.8K

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.39B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.